Talecris Biotherapeutics
United States

  Home About Talecris US Our Products Our Services Media Center Careers  
Media Center
Press Releases
Request Updates from Media Center

Press Releases


To see all our press releases, visit the archive on the Talecris corporate Web site.

  July 24, 2008
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Form of Alpha-1 Antitrypsin (AAT) From the European Commission
 
  June 16, 2008
Talecris Biotherapeutics, Inc. Provides Business Update
 
  May 22, 2008
Talecris Biotherapeutics Awarded MedAssets Supply Chain Systems' Platinum Vendor Designation
 
  May 14, 2008
Talecris Announces 2008 Application Cycle for Talents Research Grants, Presents 2007 Grant Awardees
 
  May 08, 2008
FDA Grants Priority Review of Gamunex® as a Treatment for Neurological Disorder CIDP
 

 

 

Print This Page
E-mail This Page

Talecris Biotherapeutics
Contact Talecris    Glossary    Site Map
General Conditions of Use    Privacy Statement    California Compliance
© 2008 Talecris Biotherapeutics